Tefé-Silva C, Rodrigues BG, Pascoal BB, Minante BI, Vitoreli BC, de Sousa B, arros ISB, Fortunato IM, de Castro SC. TRASTUZUMAB DERUXTECAN: NOVEL ANTIBODY-DRUG CONJUGATE TARGETING HER2 IN PATIENTS WITH GASTRIC ADENOCARCINOMA. journal [Internet]. 5Apr.2023 [cited 19Apr.2025];5(4):1-. Available from: https://japsr.in/index.php/journal/article/view/201